Nicosia

Nicosia has emerged as a life sciences hub in the Eastern Mediterranean, distinguished by its robust pharmaceutical manufacturing sector and pioneering biotechnology research.

The city is home to global industry leaders like Remedica, which exports high-quality generic medicines to over 140 countries, anchoring Cyprus’s reputation in the international drug development market.

Beyond traditional pharma, Nicosia’s healthcare innovation is fueled by a burgeoning startup ecosystem and the Research and Innovation Foundation (RIF), which facilitates the commercialization of cutting-edge medical technology.

The capital serves as a center for academic research excellence, with the University of Nicosia and the University of Cyprus leading world-ranked programs in Life Sciences and Biomedical Engineering.

Specialized institutions, such as the Molecular Medicine Research Center (cyBiobank) and the Center of Excellence in Innovation and Technology (CERIDES), drive critical advancements in genomics, cancer biology and translational medicine.

Furthermore, Nicosia is a regional leader in the One Health approach, integrating human, animal and environmental health through its specialized Veterinary and Medical schools.

The local medical device market is equally dynamic, supported by distributors like the MSJ Group that provide sophisticated diagnostic equipment and digital health solutions to the broader EU market.

With a strategic location bridging Europe and the Middle East, Nicosia offers a competitive, EU-regulated environment for clinical trials and biotech investment.

This integrated ecosystem of private industry, government incentives and top-tier academia positions Nicosia as a vital gateway for global life sciences expansion.